Symbol="BLRX"
AssetType="Common Stock"
Name="BioLineRx Ltd"
Description="BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company is headquartered in Hevel Modi'in, Israel."
CIK="1498403"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2 HAMA-AYAN STREET, MODI-IN TECHNOLOGY PARK, MODI-IN, IL"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="76184000"
EBITDA="-31463000"
PERatio="None"
PEGRatio="0.2"
BookValue="0.63"
DividendPerShare="0"
DividendYield="0"
EPS="-0.45"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.278"
ReturnOnEquityTTM="-0.628"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.45"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="12.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.764"
EVToRevenue="-"
EVToEBITDA="0.0704"
Beta="1.272"
num_52WeekHigh="1.82"
num_52WeekLow="0.55"
num_50DayMovingAverage="1.561"
num_200DayMovingAverage="1.05"
SharesOutstanding="61531000"
DividendDate="2019-07-15"
ExDividendDate="None"
symbol="BLRX"
open="1.25"
high="1.27"
low="1.20"
price="1.24"
volume="207596.00"
latest_trading_day="2023-08-25"
previous_close="1.23"
change="0.01"
change_percent="0.7311%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="14"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="86"
Volume_recent_avg="450939"
Change_recent_avg="0.01"
Delta_recent_avg="0.1"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-0.16"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="86"
Aroon_momentum_negative="14"
image_negative_thumbnail_id_1="169"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0007.jpeg"
image_negative_thumbnail_id_2="513"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0092.jpeg"
image_neutral_thumbnail_id_1="533"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0066.jpeg"
image_neutral_thumbnail_id_2="523"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0076.jpeg"
image_positive_thumbnail_id_1="616"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0092.jpeg"
image_positive_thumbnail_id_2="960"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0122.jpeg"
image_professor_thumbnail_id_1="1170"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
image_professor_thumbnail_id_2="1201"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0035.jpeg"
